Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Trends Biotechnol. 2006 Aug;24(8):339-42. Epub 2006 Jul 11.

Engineered chloroplasts as vaccine factories to combat bioterrorism.

Author information

  • Applied Biotechnology Institute, 101 Gateway Boulevard, Suite 100, College Station, TX 77845, USA. sstreatfield@fraunhofer-cmb.org

Abstract

Bacillus anthracis is ideal for making biological weapons, but the licensed anthrax vaccine is unsuitable for widespread public administration. Recombinant subunit-vaccine candidates offer potential alternatives, and plant-based production systems facilitate the inexpensive bulking of target antigens. A recent report demonstrates expression of anthrax protective antigen in tobacco chloroplasts--this material is immunogenic and protective when injected into mice. Provided an economic purification scheme can be developed, this technology holds promise for an improved vaccine.

PMID:
16815579
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk